Your session is about to expire
← Back to Search
Resilient Living Program for Cancer
N/A
Waitlist Available
Led By Deirdre Pachman, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline; week 5 (after 2nd session); week 9 (after 4th session); week 12 (one month after completing all sessions)
Awards & highlights
Study Summary
This trial seeks to improve quality of life, stress, anxiety, sleep, fatigue & resilience for those with advanced cancer & their caregivers.
Who is the study for?
This trial is for adults over 18 with stage IV solid tumor cancer and a prognosis of more than 6 but less than 18 months. Caregivers can also join if they assist a participating patient. Participants must speak English, be able to attend the first session in person, and complete questionnaires with or without help.Check my eligibility
What is being tested?
The Resilient Living Program aims to see if it can improve life quality, reduce stress and anxiety, enhance sleep and fatigue management, and build resilience for patients with advanced cancer as well as their caregivers.See study design
What are the potential side effects?
Since this program focuses on psychological support rather than medication, traditional side effects are not expected. However, participants may experience emotional discomfort when discussing personal issues during sessions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline; week 5 (after 2nd session); week 9 (after 4th session); week 12 (one month after completing all sessions)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline; week 5 (after 2nd session); week 9 (after 4th session); week 12 (one month after completing all sessions)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Anxiety
Change in Perceived Stress
Trial Design
1Treatment groups
Experimental Treatment
Group I: Resilient Living ProgramExperimental Treatment1 Intervention
All participants will be in the Resilient Living Program arm. Study participation involves participating in a 12-week stress management and resilience training program. This will involve four virtual sessions (video or phone) and answering questions about their health, well-being, and quality of life. There will also be online modules to watch and an accompanying journal (with prompts) to keep.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Resilient Living Program
2020
N/A
~50
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,207 Previous Clinical Trials
3,767,090 Total Patients Enrolled
Deirdre Pachman, MDPrincipal InvestigatorMayo Clinic
1 Previous Clinical Trials
30 Total Patients Enrolled
Deirdre R. Pachman, M.D.Principal InvestigatorMayo Clinic
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are 18 years old or older.Your estimated life expectancy is between 6 to 18 months.You must give written permission to participate in the study.You have advanced stage cancer that has spread to other parts of the body.You are taking care of someone who meets the cancer diagnosis criteria and is also participating in the study.You must be able to attend the first Resilient Living session in person.You can speak English fluently.You do not have a serious problem with your ability to think and remember things.You can fill out the survey by yourself or with help if needed.You have a high level of distress or have been identified by your care team as needing help to manage your distress.
Research Study Groups:
This trial has the following groups:- Group 1: Resilient Living Program
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there available vacancies for participants in this clinical trial?
"The trial posted on July 15th 2020 has concluded its recruitment process, as clinicaltrials.gov confirms. Nevertheless, there are an abundance of other medical studies that remain open and actively searching for volunteers; 2,476 trials to be exact."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger